Guideline Central Blog

AGA

AGA’s Ulcerative Colitis Guideline is Now Open for Public Comment

The American Gastroenterological Association (AGA) has announced that their latest guideline, “The AGA Living Guideline: Pharmacological Management of Moderate-To-Severe Ulcerative Colitis,” is now open for public comment. This guideline, aimed at supporting practitioners in the pharmacological management of moderate-to-severe ulcerative colitis (UC), features 14 recommendations designed to guide therapy decisions with a patient-centered approach. Referred […]

What's Changed & Predictions Eosinophilic Esophagitis (EoE)

Eosinophilic Esophagitis Guidelines – What’s Changed Since+ Guidelines Prediction Series

EoE (eosinophilic esophagitis) is a chronic, immune-mediated condition characterized by mucosal inflammation and esophageal dysfunction as the result of an eosinophilic-predominant immunogenic reaction. EoE, with onset typically secondary to genetic predisposition or antigen-triggered in etiology, results in damage to the esophagus that symptomatically can present as dysphagia, odynophagia, episodes of choking episodes, or can be […]

DDW 2024 Recap

DDW2024 Conference Recap: Crohn’s Disease and Ulcerative Colitis at Digestive Disease Week

The American Gastroenterological Association’s (AGA) annual meeting was held in Washington, DC from May 18-21, 2024. Digestive Disease Week® (DDW2024) is considered the leading event for gastroenterology professionals, featuring innovative advancements, networking opportunities, and the most recent research in the field. Today, we will explore some of the fascinating research presented at the DDW2024, with […]